NSCLC

You have access
ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
KATHRIN FLESCHUTZ, LISA WALTER, RUMO LEISTNER and LUCIE HEINZERLING

Anticancer Research September 2020, 40 (9) 4937-4946; DOI: https://doi.org/10.21873/anticanres.14497
You have access
NCAPH Is Required for Proliferation, Migration and Invasion of Non-small-cell Lung Cancer Cells
BYEOL KIM, SEOK WON KIM, JI-YEON LIM and SEON-JOO PARK

Anticancer Research June 2020, 40 (6) 3239-3246; DOI: https://doi.org/10.21873/anticanres.14305
You have access
Overexpression of AGR2 Is Associated With Drug Resistance in Mutant Non-small Cell Lung Cancers
THI-THU-TRANG LUU, DUC-HIEP BACH, DONGHWA KIM, RUOCI HU, HYEN JOO PARK and SANG KOOK LEE

Anticancer Research April 2020, 40 (4) 1855-1866; DOI: https://doi.org/10.21873/anticanres.14139
You have access
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA and FARKHAD MANAPOV

Anticancer Research April 2020, 40 (4) 2319-2322; DOI: https://doi.org/10.21873/anticanres.14198
You have access
Antihelminthic Niclosamide Induces Autophagy and Delayed Apoptosis in Human Non-small Lung Cancer Cells In Vitro and In Vivo
WOEI-HORNG CHAI, YI-RONG LI, SHENG-HAO LIN, YA-HUSAN CHAO, CHENG-HSIUNG CHEN, PO-CHIANG CHAN and CHING-HSIUNG LIN

Anticancer Research March 2020, 40 (3) 1405-1417; DOI: https://doi.org/10.21873/anticanres.14082
You have access
Hedgehog Pathway Activation Might Mediate Pemetrexed Resistance in NSCLC Cells
YICHAO LIU, RUDOLF M. HUBER, ROSEMARIE KIEFL, AMANDA TUFMAN and DIEGO KAUFFMANN-GUERRERO

Anticancer Research March 2020, 40 (3) 1451-1458; DOI: https://doi.org/10.21873/anticanres.14087
You have access
Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells
YUSUKE KITA, TETSUHIKO GO, NARIYASU NAKASHIMA, DAGE LIU, YOSHIMASA TOKUNAGA, XIA ZHANG, TAKAYUKI NAKANO, KAZUHITO NII, SUNG SOO CHANG and HIROYASU YOKOMISE

Anticancer Research February 2020, 40 (2) 733-741; DOI: https://doi.org/10.21873/anticanres.14004
You have access
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective Analysis
LETIZIA GIANONCELLI, GIANLUCA SPITALERI, ANTONIO PASSARO, DAVIDE RADICE, CATERINA FUMAGALLI, ESTER DEL SIGNORE, VALERIA STATI, CHIARA MATILDE CATANIA, ELENA GUERINI-ROCCO, MASSIMO BARBERIS and FILIPPO DE MARINIS

Anticancer Research January 2020, 40 (1) 427-433; DOI: https://doi.org/10.21873/anticanres.13970
You have access
Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter
QUNCHENG ZHANG, YONGAN SONG, XIANGSONG CHENG, ZHIWEI XU, OLAJUYIN AYOBAMI MATTHEW, JIA WANG, ZHIFU SUN and XIAOJU ZHANG

Anticancer Research October 2019, 39 (10) 5461-5471; DOI: https://doi.org/10.21873/anticanres.13739
You have access
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment
LUKAS KÄSMANN, JULIAN TAUGNER, CHUKWUKA EZE, OLARN ROENGVORAPHOJ, MAURICE DANTES, KATHRIN GENNEN, MONIKA KARIN, OLEG PETRUKHNOV, AMANDA TUFMAN, CLAUS BELKA and FARKHAD MANAPOV

Anticancer Research September 2019, 39 (9) 5077-5081; DOI: https://doi.org/10.21873/anticanres.13701

Main menu

User menu

Search

NSCLC

Pages